Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Therapeutic delivery

• Publication date

  2014-12-10

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.4155/tde.14.79PMID 25491670PMCID PMC4451574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time Analysis of Poly(Lactic-Co-Glycolic) Acid Nanoparticle Uptake by Major Organs Following Acute Intravenous and Oral Administration in Mice and Rats

  2013cited by this paper
• Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.

  2013cited by this paper
• Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.

  2013cited by this paper
• Encyclopedia of Life Sciences

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Administration, distribution, metabolism and elimination of polymer therapeutics.

  2012cited by this paper
• Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats

  2012cited by this paper
• Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

  2012cited by this paper
• The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.

  2012cited by this paper
• Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.

  2012cited by this paper
• Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective.

  2012cited by this paper
• Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate

  2011cited by this paper
• Recent advances of chitosan nanoparticles as drug carriers

  2011cited by this paper
• Fate of polymeric nanocarriers for oral drug delivery

  2011cited by this paper
• Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

  2010cited by this paper
• Chitosan nanoparticles: a promising system in novel drug delivery.

  2010cited by this paper
• In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles.

  2010cited by this paper
• Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.

  2010cited by this paper
• The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery.

  2010cited by this paper
• Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake.

  2009cited by this paper
• Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

  2009cited by this paper
• Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

  2009cited by this paper
• Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

  2008cited by this paper
• Nanoparticles with entrapped α-tocopherol: synthesis, characterization, and controlled release

  2008cited by this paper
• PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution.

  2008cited by this paper
• Nanoparticles - A Review

  2007cited by this paper
• Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution.

  2007cited by this paper
• What do we (need to) know about the kinetic properties of nanoparticles in the body?

  2007cited by this paper
• Synthesis and characterization of PLGA nanoparticles

  2006cited by this paper
• pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.

  2004cited by this paper
• Effect of Chitosan on Epithelial Cell Tight Junctions

  2004cited by this paper
• Oral peptide and protein delivery: unfulfilled promises?

  2003cited by this paper
• Emerging trends in oral delivery of peptide and protein drugs.

  2003cited by this paper
• Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

  2002cited by this paper
• Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats.

  2001cited by this paper
• Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.

  2001cited by this paper
• The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

  2000cited by this paper
• EFFICIENCY IN PEPTIDE COUPLING : 1-HYDROXY-7-AZABENZOTRIAZOLE VS 3,4-DIHYDRO-3-HYDROXY-4-OXO-1,2,3-BENZOTRIAZINE

  1995cited by this paper
• Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice

  1994cited by this paper
• A physiologically based model for gastrointestinal absorption and excretion of chemicals carried by lipids.

  1993cited by this paper
• Gastrointestinal absorption of drugs.

  1989cited by this paper
• Gastrointestinal absorption of drugs.

  1989cited by this paper

• Emerging nanoparticle-based strategies for advanced cancer imaging and diagnosis.

  2025cites this paper
• Synthesis of chitosan-modified poly (lactic-co-glycolic acid) microparticles with pH-dependent controlled-release kinetics to enhance the delivery of potential antidiarrheal medicinal plant extract to the lower gastrointestinal tract

  2025cites this paper
• Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.

  2024cites this paper
• Nano- and microplastic PBK modeling in the context of human exposure and risk assessment.

  2024cites this paper
• Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function.

  2023cites this paper
• Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery

  2021cites this paper
• Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications

  2021cites this paper
• SP94-Targeted Triblock Co-Polymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in vivo.

  2020cites this paper
• Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity

  2020cites this paper
• Toxicity of polymeric nanomaterials

  2020cites this paper
• Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer's disease: A non-invasive approach.

  2020cites this paper
• Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part II: In vitro and in vivo Kinetics Study

  2020cites this paper
• Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease

  2020cites this paper
• Topical nanodelivery system of lutein for the prevention of selenite-induced cataract.

  2019cites this paper
• Oral Silica Nanoparticles Lack of Neurotoxic Effects in a Parkinson’s Disease Model: A Possible Nanocarrier?

  2019cites this paper
• Nanoparticles for improvement in oral bioavailability

  2019cites this paper
• Surface engineering of resveratrol to improve neuro-protection and functional recovery after spinal cord injury in rat

  2019cites this paper
• Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B

  2018cites this paper
• Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats

  2017cites this paper
• Biodistribution of orally administered poly(lactic-co-glycolic) acid nanoparticles for 7 days followed by 21 day recovery in F344 rats

  2017cites this paper
• Investigation on hemolytic effect of poly(lactic co-glycolic) acid nanoparticles synthesized using continuous flow and batch processes

  2017cites this paper
• CHITOSAN MODIFIED POLY(LACTIC-CO-GLYCOLIC) ACID NANOPARTICLES INTERACTION WITH NORMAL, PRECANCEROUS KERATINOCYTES AND DENTAL PULP CELLS

  2017cites this paper
• Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes

  2016cites this paper
• Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.

  2016cites this paper
• Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats

  2016cites this paper
• Poly (Lactic Co-Glycolic) Acid Nanoparticles: Synthesis Using Millifluidic Chip and Interaction with Red Blood Cells

  2015cites this paper